<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04893694</url>
  </required_header>
  <id_info>
    <org_study_id>Oral SARS 2</org_study_id>
    <nct_id>NCT04893694</nct_id>
  </id_info>
  <brief_title>the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection</brief_title>
  <official_title>the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fayoum University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health and Population, Egypt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fayoum University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a&#xD;
      global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the&#xD;
      receptor angiotensin-converting enzyme 2 (ACE2) through scRNA-seq data analyses. The study&#xD;
      identified the organs that are at risk and are vulnerable to SARS-CoV-2 infection. Therefore,&#xD;
      cells with ACE2 receptor distribution may become host cells for the virus and cause&#xD;
      inflammatory response in related organs and tissues, such as the tongue mucosa and salivary&#xD;
      glands. These results suggest that oral mucosa could be a target of SARS-CoV-2 infection&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The oral cavity is particularly susceptible to viral infection with several viruses such as&#xD;
      herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially&#xD;
      salivary glands and soft tissues . Moreover, oral mucosa can be affected by secondary&#xD;
      pathological process of a bacterial or fungal nature due to viral immunosuppression. The oral&#xD;
      cavity could be considered a &quot;biological barometer&quot; of both viral infection and viral&#xD;
      immunosuppression advancement .&#xD;
&#xD;
      The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a&#xD;
      global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the&#xD;
      receptor angiotensin-converting enzyme 2 (ACE2) through scRNA-seq data analyses. The study&#xD;
      identified the organs that are at risk and are vulnerable to SARS-CoV-2 infection. Therefore,&#xD;
      cells with ACE2 receptor distribution may become host cells for the virus and cause&#xD;
      inflammatory response in related organs and tissues, such as the tongue mucosa and salivary&#xD;
      glands. These results suggest that oral mucosa could be a target of SARS-CoV-2 infection .&#xD;
&#xD;
      Although many authors reported the presence of oral lesion associated with SARS-CoV2&#xD;
      infection, the prevalence of the oral manifestation and the range of oral manifestation are&#xD;
      still unknown. Further studies are necessary to better understanding of the symptoms of the&#xD;
      SARS-CoV2 virus in order to faster detection. A multidisciplinary team following the patients&#xD;
      could be the key in treatment of the infection and faster recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Actual">July 15, 2021</completion_date>
  <primary_completion_date type="Actual">June 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oral Manifestation</measure>
    <time_frame>one week</time_frame>
    <description>presence or absence of Oral Manifestation in SARS-CO2</description>
  </primary_outcome>
  <enrollment type="Actual">385</enrollment>
  <condition>SARS-CoV2 Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This is a multicenter cross- sectional study to study the prevalence of oral manifestation&#xD;
        among patients with SARS-CoV2 infection and identify the range of the oral manifestation&#xD;
        and site of lesions&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A diagnosis of SARS-CoV2 with PCR.&#xD;
&#xD;
          -  Age range from 18-60 years old&#xD;
&#xD;
          -  Hospital admission not more than 10 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or contraceptive pills&#xD;
&#xD;
          -  Lactation&#xD;
&#xD;
          -  Any auto-immune disease that could affect the oral mucosa&#xD;
&#xD;
          -  On any neoplastic therapy.&#xD;
&#xD;
          -  Uncontrolled diabetes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Dentistry</name>
      <address>
        <city>Fayoum</city>
        <zip>63514</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb 24;12(1):8. doi: 10.1038/s41368-020-0074-x.</citation>
    <PMID>32094336</PMID>
  </reference>
  <reference>
    <citation>Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis. 2021 Apr;27 Suppl 3:703-706. doi: 10.1111/odi.13359. Epub 2020 May 6.</citation>
    <PMID>32304276</PMID>
  </reference>
  <reference>
    <citation>Riad A, Klugar M, Krsek M. COVID-19-Related Oral Manifestations: Early Disease Features? Oral Dis. 2020 Jun 30. doi: 10.1111/odi.13516. [Epub ahead of print]</citation>
    <PMID>32603497</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 15, 2021</study_first_submitted>
  <study_first_submitted_qc>May 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2021</study_first_posted>
  <last_update_submitted>August 21, 2021</last_update_submitted>
  <last_update_submitted_qc>August 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fayoum University</investigator_affiliation>
    <investigator_full_name>Alshaimaa Ahmed shabaan</investigator_full_name>
    <investigator_title>associate professor in oral &amp; maxillofacial Surgery Department</investigator_title>
  </responsible_party>
  <keyword>SARS-CoV2</keyword>
  <keyword>Oral Manifestation</keyword>
  <keyword>prevalence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Oral Manifestations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

